---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-001468"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2026-09-09T14:12:04+00:00"
generated_at: "2026-09-09T14:13:05.167602+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lexaria raises ~$5.9M via warrant exercise at $12.92/share; issues new warrants

## Summary
- 453,969 existing warrants exercised at reduced $12.92/share, gross proceeds ~$5.9M before fees.
- New Series A warrants (5-yr, $12.67) and Series B warrants (18-mo, $12.67) issued for 453,969 shares each.
- H.C. Wainwright acts as placement agent; fee 7% of gross proceeds plus 15,889 agent warrants at $16.15.
- CEO cites $2.6M Australian Tax Office rebate received; proceeds to fund 2027 operations and R&D.
- Closing expected Sept 9, 2026; resale registration statement to be filed within 30 days.

## SEC filing metadata
- accession: 0001640334-26-001468
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2026-09-09T14:12:04+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033426001468/0001640334-26-001468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033426001468/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-001468
- JSON: https://secwatch.observer/filing/0001640334-26-001468.json
- Plain text: https://secwatch.observer/filing/0001640334-26-001468.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.